Carlyle has acquired Abingworth, according to a news release.

Abingworth, with U.S. offices in Boston and Menlo Park, Calif., is a transatlantic life sciences investment firm. Founded in 1973, the firm reports approximately $2 billion in assets under management. To date, Abingworth has invested in 179 life science companies, with its investments falling into seed and early-stage, development stage and clinical co-development.

Carlyle, with its U.S. headquarters in Washington, D.C., is a global investment firm that deploys private capital across three business segments: global private equity, global credit and investment solutions. Founded in 1987, the firm targets companies in healthcare and many other industries.

Terms of the acquisition were not disclosed.